Clinical Trial Update: Phosphoproteomic Profile of Children With Down Syndrome

View source ↗

Summary

This clinical trial update reports on a completed study evaluating the phosphoproteomic profiles in children with Down syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: Perha Pharmaceuticals | Conditions: Down Syndrome | Status: COMPLETED